林格宁作为一种生物活性添加剂,用于含可萨的药物片中.
Andreea Creteanu1, Gabriela Lisa2, Cornelia Vasile3
1Department of Pharmaceutical Technology, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iași, Romania.
Molecules (Basel, Switzerland)
|April 26, 2025
概括
生物活性添加剂利格宁被用于制造具有改善抗氧化和抗微生物特性的药物装载片. 这项研究证明了红素的存在.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 水友性矩阵对于控制药物释放至关重要.
- 利格宁的生物活性特性正在为制药应用而被探索.
研究的目的:
- 为了研究红素作为药物装载片中的生物活性添加剂.
- 为了评估红素对从水友基基准中释放的糖的影响.
- 评估含有红素的片剂的抗氧化和抗微生物活性.
主要方法:
- 使用Kollidon® SR (KOL) 和奇托 (CHT) 作为矩阵形成剂制备500毫克片.
- 将素 (LIG) 纳入药片配方 (FLa,FLb,FLc) 中.
- 使用FTIR,XRD,TG,DSC和体外溶解试验进行评估.
主要成果:
- 利格宁影响了氧沙 (CLZ) 的释放特性.
- 观察到一个两阶段的释放机制:一个爆发效应,随后是长时间的释放.
- 含有红素的片剂表现出增强的抗氧化和抗微生物活性,取决于剂量.
- 在配方FLc.中,抗氧化活性增加了21.36%.
- 抗微生物活性增强了对测试的病原体,随着宁度的增加.
结论:
- 素可以作为多功能药品生物活性添加剂.
- 氨酸的加入改善了药片的抗氧化和抗菌性能.
- 利格宁的特性支持其在各种制药应用中的使用,可能降低药物剂量.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
101
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
101
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
155
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
155
Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109


